While anti-AQP4 autoantibodies in NMO patients undoubtedly exert cytotoxic effects on astrocytes [7,8], other pathophysiological mechanisms relying on an alteration of AQP4 functions, have been incriminated [9,10]. Here, AQP4 is linked to neuromyelitis optica.